JFGIW
ABEO icon

Johnson Financial Group Inc (Wisconsin)’s Abeona Therapeutics ABEO Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed – – 757
2021
Q1 		$0 Buy
+4
New +$220 ﹤0.01% 636

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s ABEO Position: Q2 2021 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Abeona Therapeutics (ABEO) in Q2 2021, closing a stake of 4 shares.

Johnson Financial Group Inc (Wisconsin) first reported a position in ABEO in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 70 funds tracked by Wall St. Rank hold ABEO as of Q2 2021.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Abeona Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 4 Abeona Therapeutics shares in Q2 2021.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Abeona Therapeutics in Q1 2021 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s Abeona Therapeutics position peaked at $0 in Q1 2021.
  • 70 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2021.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2021, filed 13 Aug 2021.